홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CNSP
#4004
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+4.29%
월간 변동
-48.11%
6달 변화
-49.76%
년간 변동율
+35.62%
이전 종가
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
양
4
마켓
주식
헬스케어
CNSP
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
-1.6
-1.17
-11.08
-1.71
-1.11
Return on equity %
0.68
-2.12
-1.88
4.25
-2.41
-1.41
Return on invested capital %
6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
—
Gross margin %
100
—
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
24.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0
0
Solvency ratios
Debt to assets ratio
0.06
0.09
0.07
—
—
—
Debt to equity ratio
0.07
0.12
0.11
—
—
—
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.08
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-204.35
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
18.94 K
—
—
—
Cash per share
—
—
221.53 K
4 369.53
202.85
310.69
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
390.8
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Working capital per share
—
—
168.41 K
-36.17 K
192.58
292.07
Book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
뉴스
CNS 파마슈티컬, 경영진에 3명의 임원 새로 임명
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero, DDoS 방어 플랫폼 기능 강화 발표
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals, CEO 사임 후 주가 하락
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals, CEO에 라미 레빈 임명
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals, 주주총회서 주식 수 증가 및 이사 선임 승인
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript